| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.28 (Beat by $0.12) |
| EPS GAAP Actual | $0.28 (Beat by $0.12) |
| Revenue Actual | $0.079516B |
| Revenue Surprise | Beat by $79.516M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.2 |
| EPS GAAP Estimate | $0.2 |
| Revenue Estimate | $0.07346625B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2026 | 2.40857 | 8.36 | 2.15667 | 2.76471 | 5 |
| Jun 2025 | 2.44 | 8.25 | 2.16 | 3 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0 | 0 | 0.079516B | 15.51% | 79.52M |
| FQ1 2025 (Mar 2025) | 0.227 | 0.227 | 0.07596B | -26% | 75.96M |
| FQ4 2024 (Dec 2024) | 0.166 | 0.166 | 0.063368B | -64.46% | 63.37M |
| FQ3 2024 (Sep 2024) | -0.31 | -0.31 | 0.065359B | 100% | 65.36M |
| FQ2 2024 (Jun 2024) | -0.92 | -0.92 | 0.067182B | -148.25% | 67.18M |
| FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 0.095708B | -66.33% | 95.71M |
| FQ3 2013 (Sep 2013) | 0.0588 | 0.0588 | 0.041086B | 100% | 41.09M |
| FQ4 2013 (Dec 2013) | 0.0588 | 0.0588 | 0.041086B | 100% | 41.09M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0.2
Consensus Revenue Estimates
0.07346625B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.39 | -- | 0.38533 | 0.39613 | 1 |
| FQ1 2027 (Mar 2027) | 0.42 | -- | 0.41497 | 0.4266 | 1 |
| FQ4 2026 (Dec 2026) | 0.36 | -- | 0.35569 | 0.36566 | 1 |
| FQ3 2026 (Jul 2026) | 0.93 | -- | 0.85133 | 1.08607 | 0 |
| FQ2 2026 (Jun 2026) | 0.5 | -- | 0.49611 | 0.50389 | 1 |
| FQ1 2026 (Mar 2026) | 0.42 | 45.95 | 0.41673 | 0.42327 | 1 |
| FQ4 2025 (Dec 2025) | 0.2 | 17 | 0.17364 | 0.22095 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.08B | -- | 0.08B | 0.09B | 4 |
| FQ1 2027 (Mar 2027) | 0.09B | -- | 0.09B | 0.09B | 4 |
| FQ4 2026 (Dec 2026) | 0.08B | -- | 0.08B | 0.08B | 4 |
| FQ3 2026 (Jul 2026) | 0.14B | -- | 0.13B | 0.15B | 2 |
| FQ2 2026 (Jun 2026) | 0.09B | 16.18 | 0.09B | 0.1B | 1 |
| FQ1 2026 (Mar 2026) | 0.09B | 17.91 | 0.09B | 0.09B | 1 |
| FQ4 2025 (Dec 2025) | 0.07B | 13.75 | 0.07B | 0.08B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | 0.227 | 0.227 | 100% | |
| FQ4 2024 (Dec 2024) | 0.166 | 0.166 | 100% | |
| FQ3 2024 (Sep 2024) | -0.31 | -0.31 | 100% | |
| FQ2 2024 (Jun 2024) | -0.92 | -0.92 | 100% | |
| FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 100% | |
| FQ3 2013 (Sep 2013) | 0.0588 | 0.0588 | 100% | |
| FQ4 2013 (Dec 2013) | 0.0588 | 0.0588 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.08B | $79.52M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.08B | $75.96M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.06B | $63.37M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.07B | $65.36M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.07B | $67.18M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.1B | $95.71M | 100% |
| FQ3 2013 (Sep 2013) | $0B | $0.04B | $41.09M | 100% |
| FQ4 2013 (Dec 2013) | $0B | $0.04B | $41.09M | 100% |